Beryl McCormick Selected Research

Conjunctival Neoplasms

3/2015

Intraoperative high-dose rate of radioactive phosphorus 32 brachytherapy for diffuse recalcitrant conjunctival neoplasms: a retrospective case series and report of toxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Beryl McCormick Research Topics

Disease

53	Breast Neoplasms (Breast Cancer) 05/2022 - 09/2002
36	Neoplasms (Cancer) 01/2021 - 03/2003
7	Neoplasm Metastasis (Metastasis) 01/2020 - 09/2004
6	Noninfiltrating Intraductal Carcinoma (DCIS) 11/2021 - 04/2010
4	Retinoblastoma (Glioblastoma, Retinal) 11/2013 - 01/2002
3	Contracture 09/2020 - 03/2004
3	Triple Negative Breast Neoplasms 10/2013 - 10/2012
2	Second Primary Neoplasms (Neoplasms, Second) 01/2021 - 10/2007
2	Margins of Excision 12/2019 - 01/2016
2	Inflammatory Breast Neoplasms 07/2019 - 07/2010
2	Fibrosis (Cirrhosis) 01/2019 - 01/2014
2	Ductal Carcinoma 11/2012 - 12/2005
2	Carcinoma (Carcinomatosis) 07/2012 - 01/2005
1	Mastodynia 12/2021
1	COVID-19 07/2020
1	Infections 07/2020
1	Circulating Neoplastic Cells 01/2020
1	Erythema 01/2019
1	Dermatitis 01/2018
1	Extranodal Extension 01/2016
1	Conjunctival Neoplasms 03/2015
1	Melanoma (Melanoma, Malignant) 11/2014
1	Uveal melanoma 11/2014
1	Telangiectasis (Telangiectasia) 01/2014
1	Fat Necrosis 01/2014
1	Carcinoma in Situ 08/2013
1	Hyperthermia 03/2007
1	Radiation Pneumonitis 09/2005
1	Lymphedema (Milroy Disease) 11/2004
1	Necrosis 01/2002

Drug/Important Bio-Agent (IBA)

10	Estrogen ReceptorsIBA 01/2021 - 09/2004
6	Hormones (Hormone)IBA 01/2017 - 07/2010
3	Tamoxifen FDA LinkGeneric 11/2021 - 09/2004
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 01/2009
3	ErbB Receptors (EGF Receptor)IBA 01/2021 - 04/2012
2	Protons (Proton)IBA 12/2021 - 01/2019
2	Trastuzumab (Herceptin)FDA Link 08/2015 - 04/2012
2	Taxoids (Taxanes)IBA 07/2010 - 09/2005
2	taxaneIBA 07/2010 - 09/2005
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 04/2019
1	Mometasone Furoate (Nasonex)FDA LinkGeneric 01/2018
1	eucerinIBA 01/2018
1	Phosphorus (Red Phosphorus)IBA 03/2015
1	SteroidsIBA 07/2012
1	human ERBB2 proteinIBA 04/2012
1	3,6-dimethylaminodibenzopyriodonium citrateIBA 07/2010
1	Dihydrotachysterol (AT 10)IBA 07/2008
1	Carboplatin (JM8)FDA LinkGeneric 10/2007
1	CobaltIBA 01/2002

Therapy/Procedure

47	Radiotherapy 05/2022 - 01/2002
26	Therapeutics 01/2021 - 09/2004
24	Segmental Mastectomy (Lumpectomy) 12/2021 - 09/2002
16	Mastectomy (Mammectomy) 12/2021 - 09/2004
16	Drug Therapy (Chemotherapy) 01/2021 - 01/2002
6	Tissue Expansion Devices (Tissue Expander) 09/2020 - 03/2004
6	Brachytherapy 01/2016 - 10/2008
3	Re-Irradiation 12/2021 - 01/2020
3	Biological Therapy 03/2016 - 04/2014
2	Adjuvant Chemotherapy 01/2021 - 01/2008
2	Aftercare (After-Treatment) 01/2020 - 01/2005
2	Mammaplasty (Breast Reconstruction) 05/2012 - 07/2008
2	Adjuvant Radiotherapy 07/2011 - 01/2009
2	Lymph Node Excision (Lymph Node Dissection) 01/2008 - 09/2002
1	Contraindications 09/2020
1	Palliative Care (Palliative Therapy) 12/2019
1	Proton Therapy 01/2019
1	Neoadjuvant Therapy 12/2015
1	Salvage Therapy 11/2014
1	Catheters 01/2014
1	Simple Mastectomy 11/2012
1	Modified Radical Mastectomy (Mastectomy, Modified) 05/2012
1	Combined Modality Therapy 07/2010
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2009
1	Operative Surgical Procedures 07/2008
1	Anesthesia 07/2008
1	Tissue Expansion 01/2008